DE3176479D1 - Composition for increasing blood pressure - Google Patents

Composition for increasing blood pressure

Info

Publication number
DE3176479D1
DE3176479D1 DE8181902147T DE3176479T DE3176479D1 DE 3176479 D1 DE3176479 D1 DE 3176479D1 DE 8181902147 T DE8181902147 T DE 8181902147T DE 3176479 T DE3176479 T DE 3176479T DE 3176479 D1 DE3176479 D1 DE 3176479D1
Authority
DE
Germany
Prior art keywords
blood pressure
composition
increasing blood
patient
nervous system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181902147T
Other languages
English (en)
Inventor
Richard J Wurtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3176479D1 publication Critical patent/DE3176479D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8181902147T 1981-07-15 1981-07-15 Composition for increasing blood pressure Expired DE3176479D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1981/000964 WO1983000285A1 (en) 1981-07-15 1981-07-15 Process and composition for increasing blood pressure

Publications (1)

Publication Number Publication Date
DE3176479D1 true DE3176479D1 (en) 1987-11-19

Family

ID=22161323

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181902147T Expired DE3176479D1 (en) 1981-07-15 1981-07-15 Composition for increasing blood pressure

Country Status (5)

Country Link
EP (1) EP0083338B1 (de)
JP (1) JPS58501118A (de)
AT (1) ATE30210T1 (de)
DE (1) DE3176479D1 (de)
WO (1) WO1983000285A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096712A (en) * 1990-03-06 1992-03-17 Interneuron Pharmaceuticals, Inc. Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034543A1 (en) * 1969-02-13 1970-12-11 Etd Experimentales Centre L-tyrosine contg compsn in glucose for - treating fatigue syndrome
US3651237A (en) * 1970-02-11 1972-03-21 Experimentales Et Cliniques De Treating of aggression and reduction of fatigue syndromes with l-tyrosine
US4327112A (en) * 1978-04-24 1982-04-27 Massachusetts Institute Of Technology Process for increasing blood pressure
DE2967257D1 (en) * 1978-04-24 1984-11-22 Massachusetts Inst Technology Composition for regulating dopamine or norepinephrine levels in neuronal synapses
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
US4224343A (en) * 1979-04-05 1980-09-23 Massachusetts Institute Of Technology Process and composition for decreasing blood serum prolactin levels

Also Published As

Publication number Publication date
WO1983000285A1 (en) 1983-02-03
EP0083338B1 (de) 1987-10-14
ATE30210T1 (de) 1987-10-15
EP0083338A4 (de) 1984-09-19
EP0083338A1 (de) 1983-07-13
JPS58501118A (ja) 1983-07-14

Similar Documents

Publication Publication Date Title
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
DE69003392D1 (de) Dosisform zur oralen verabreichung des hypoglykämischen glipizids.
DK0913156T3 (da) Anvendelse af aktiveret protein C til behandling af hyperkoagulationstilstande i forbindelse med sepsis
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
CA2151724A1 (en) Antipyretic and Analgesic Methods and Compositions Containing Optically Pure R-Ketorolac
GR76810B (de)
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
PT88138A (pt) Processo para a producao de uma forma de administracao ou de dosagem para substancias medicinais activas por meio de um processo de impressao
MY103746A (en) Improvements in or relating to somatostatins
KR950007848A (ko) (S)-(-)-α-에틸-2-옥소-1-피롤리딘아세트아미드를 사용한 불안치료방법
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
KR910700069A (ko) Gm-csf를 사용한 백혈구 기능장애의 치료
DE3176479D1 (en) Composition for increasing blood pressure
KR920702225A (ko) 약학 조성물
KR890000108A (ko) 종양 치료용 약제학적 조성물
MY101916A (en) Etoposide oral dosage form.
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
KR890007728A (ko) 진통제 제조방법
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
KR880002535A (ko) 약제로서의 15-데옥시스퍼구알린의 용도
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
AU551108B2 (en) Analgesic potentiation of zomepirac with butorphanol
AU5198686A (en) Praparat zur intramuskularen injektion von medikamenten vitaminen oder impfstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee